Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
evt-101 glutamate receptor ionotropic nmda 2b NA Successful target TTD , DGIDB Pain[MeSHID:D010146]
Parkinson Disease[MeSHID:D010300]
Neuralgia[MeSHID:D009437]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.38 discontinued in phase 2 antagonist
evt-101 glutamate receptor ionotropic, nmda 2b small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Parkinson Disease[MeSHID:D010300]
Neuralgia[MeSHID:D009437]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.38 investigational antagonist
evt-101 glutamate receptor ionotropic, nmda 2b small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Parkinson Disease[MeSHID:D010300]
Neuralgia[MeSHID:D009437]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.38 investigational unknown
evt-101 glutamate receptor ionotropic nmda 2b NA Successful target TTD , DGIDB Pain[MeSHID:D010146]
Parkinson Disease[MeSHID:D010300]
Neuralgia[MeSHID:D009437]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.38 discontinued in phase 2 unknown
evt-101 retinoic acid receptor rxr-alpha small molecule NA drugbank Pain[MeSHID:D010146]
Parkinson Disease[MeSHID:D010300]
Neuralgia[MeSHID:D009437]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational unknown
click here to return to the previous page